Testing a phone app to help control high blood pressure in China and Argentina
Tests an app-based telecare plan with usual visits in adults with uncontrolled blood pressure.
Plain-language title generated from the registry record
Registry title: Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
Key facts
- Where
- Jiangse and Shanghai, ChinaSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT03206814, who can take part
Where in China
- Jiangsu Province Official HospitalJiangse, ChinaNo longer taking part
- Ruijin Hospital NorthShanghai, ChinaTaking people
- Shanghai Institute of HypertensionShanghai, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Istituto Auxologico Italiano
- Trial code
- NCT03206814
- Record updated
- 27 February 2025
- Original description
The CHARGE-APP project will investigate whether an innovative management strategy of hypertension based on the combination of usual care visits and ESH CARE App compared to standard care, is associated with differences in outcome, including control rate of office, home and ambulatory BP, cardiovascular and renal intermediate end points at one year, and changes in a number of blood pressure-related variables throughout the study.Read full original descriptionShow less
Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System
The CHARGE-APP project will investigate whether an innovative management strategy of hypertension based on the combination of usual care visits and ESH CARE App compared to standard care, is associated with differences in outcome, including control rate of office, home and ambulatory BP, cardiovascular and renal intermediate end points at one year, and changes in a number of blood pressure-related variables throughout the study.
Inclusion: Male and female subjects; Age 18-80 years; Either the patient or another person close to him/her should possess a smartphone compatible with the ESH CARE app and be capable of using it; Uncontrolled (untreated or treated) hypertension, defined as office BP ≥140/90 mmHg, and Ambulatory 24h ABP ≥130/80 mmHg.
Exclusion: Severe uncontrolled hypertension (i.e. BP ≥200/120 mmHg despite treatment); Known secondary hypertension; Unstable clinical conditions or severe disease with short life expectation; History of gastrointestinal surgery or disorders which could interfere with drug absorption; History of malignancy including leukaemia and lymphoma (but not basal cell skin cancer) within the last 5 years; History of clinically significant autoimmune disorders such as systemic lupus erythematosus; History of drug or alcohol abuse within the last 5 years; History of non-compliance to medical regimens and/or patients who are considered potentially unreliable; Dementia (clinical diagnosis); eGFR <45 mL/min/1.73 m2 (CKD-EPI creatinine equation 2009); Hepatic disease as determined by either AST or ALT values > 2 times the upper limit of normal; Orthostatic hypotension (SBP fall > 20 mmHg on standing); Known atrial fibrillation; Inability or unwillingness to give free informed consent; Inability to use even simple communication technologies; Pregnancy or planned pregnancy during study period.